Recombineering strategies for developing next generation BAC transgenic tools for optogenetics and beyond

Area of Science:

• Neuroscience
• Genetics
• Molecular Biology

Background:

• Bacterial Artificial Chromosome (BAC) transgenic rodent lines are vital for precise molecular targeting of cell types in the mammalian central nervous system.
• These tools have been instrumental in the optogenetic revolution, enabling targeted expression of optogenetic probes and Channelrhodopsin-2 (ChR2).

Purpose of the Study:

• To address the issue of confounds in existing BAC transgenic lines due to the presence of "extra" genes.
• To propose and validate strategies for developing next-generation BAC transgenic lines devoid of extraneous genes.

Main Methods:

• Development of strategies to remove "extra" genes from BAC DNA sequences.
• Testing the efficacy and reproducibility of these strategies across several distinct BAC clones.
• Assessing the impact of gene removal on intended cell-type specific transgene expression patterns.

Main Results:

• Demonstrated that strategies for removing "extra" genes from BAC constructs are simple and reproducible.
• Provided evidence that these strategies do not disrupt the desired cell-type specific transgene expression.
• Successfully generated BAC transgenic lines free from the confounds of additional gene dosage.

Conclusions:

• The proposed strategies offer a significant improvement for BAC transgenesis, leading to more reliable and accurate genetic targeting.
• These methods can be widely implemented across diverse scientific disciplines utilizing BAC transgenic models.
• The development of "cleaner" BAC lines will enhance the precision and validity of future neuroscience research.